Kala chana soup and bone broth offer distinct nutritional benefits. Kala chana provides more protein, fiber, and iron for energy and satiety, while bone broth excels in collagen for joint and gut ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Kala Pharmaceuticals ( (KALA)) has shared ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Kala Pharmaceuticals ( ...

Kala Bio will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the drug developer's shares down 93% in ...

ARLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

Lucknow: The Khadi Bhawan in Lucknow came alive on Friday with the inauguration of the Mati Kala Mahotsav 2025, a 10-day celebration of Uttar Pradesh's traditional pottery and terracotta craftsmanship ...

(RTTNews) - KALA Bio, Inc. (KALA) on Monday announced that its CHASE Phase 2b study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED) did not meet the primary endpoint of ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

Kala Bio missed the primary endpoint in the study for its treatment of Persistent Corneal Epithelial Defect, an eye defect, and said it would stop development of the drug, called KPI-012. The company ...

Chief minister Bhagwant Mann on Wednesday launched ‘Mission Chardi Kala’—a global fundraising campaign to raise funds for the rehabilitation efforts for Punjab flood victims. Punjab Chief minister ...

ARLINGTON, Mass. - Kala Bio, Inc. (NASDAQ:KALA), a $133.75 million market cap biotech company whose stock has surged 174.5% year-to-date, announced Monday that its Phase 2b clinical trial of KPI-012 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.